BBIOVSSXTC• 28 Days (Normalized)
BBIO vs SXTC (BridgeBio Pharma Inc. vs China SXT Pharmaceuticals Inc.)
Showing Closing Date Range from Sep 11 to Oct 9, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBIO Performance $65.35
-9.79%
BridgeBio Pharma Inc.
Normalized Baseline0.00%
SXTC Performance $0.15
-94.18%
China SXT Pharmaceuticals Inc.
Normalized Baseline0.00%
Alpha Spread Margin BBIO LEADS
+84.39 pts
BBIO outperforming by 84.39 percentage points
BBIOSXTC
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBIO SXTC
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(21 dates)
| Date | BBIO Price | BBIO Gain (%) | SXTC Price | SXTC Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 09, 2026 | $65.35 | -9.79% | $0.15 | -94.18% | +84.39% |
| Oct 08, 2026 | $65.04 | -10.22% | $0.34 | -86.56% | +76.34% |
| Oct 07, 2026 | $66.50 | -8.20% | $2.83 | +10.55% | -18.75% |
| Oct 06, 2026 | $66.96 | -7.56% | $1.25 | -51.17% | +43.61% |
| Oct 05, 2026 | $66.14 | -8.70% | $2.08 | -18.75% | +10.05% |
| Oct 02, 2026 | $67.25 | -7.16% | $2.41 | -5.86% | -1.30% |
| Oct 01, 2026 | $- | $2.96 | +15.62% | - | |
| Sep 30, 2026 | $- | $3.01 | +17.58% | - | |
| Sep 29, 2026 | $- | $2.81 | +9.77% | - | |
| Sep 28, 2026 | $- | $2.52 | -1.56% | - | |
| Sep 25, 2026 | $65.25 | -9.92% | $- | - | |
| Sep 24, 2026 | $66.28 | -8.50% | $- | - | |
| Sep 23, 2026 | $65.71 | -9.29% | $2.51 | -1.95% | -7.34% |
| Sep 22, 2026 | $69.23 | -4.43% | $- | - | |
| Sep 21, 2026 | $66.58 | -8.09% | $2.38 | -7.03% | -1.06% |
Page 1 of 2